| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000011320 |
| Receipt No. | R000013205 |
| Official scientific title of the study | Comparison of curative effect of latanoprost and unoprostone in patients with nomal tension glaucoma (IOP<=15mmHg). |
| Date of disclosure of the study information | 2013/07/30 |
| Last modified on | 2018/08/17 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Comparison of curative effect of latanoprost and unoprostone in patients with nomal tension glaucoma (IOP<=15mmHg). | |
| Title of the study (Brief title) | Comparison of curative effect of latanoprost and unoprostone in patients with nomal tension glaucoma (IOP<=15mmHg). | |
| Region |
|
|
| Condition | ||
| Condition | Glaucoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare curative effect of latanoprost and unoprostone in patients with nomal tension glaucoma. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | To study MD of baseline and 3 years later using latanoprost and unoprostone. |
| Key secondary outcomes | 1) To study CPSD or TD of baseline and 3 years later using latanoprost and unoprostone.
2) To study transition MD, CPSD or TD of baseline to 3 years later using latanoprost and unoprostone. 3) To comparare MD, CPSD or TD between groups of using latanoprost and unoprostone for 3 years. 4) To study transition IOP of baseline to 3 years later using latanoprost and unoprostone. 5) To comparare IOP between groups of using latanoprost and unoprostone. 6) Adverse events in each groups. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Using latanoprost for 3 years. | |
| Interventions/Control_2 | Using unoprostone for 3 years. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with normal tension glaucoma setting following conditions.
1)IOP <= 15 mmHg in no medication. 2)MD >= -12 dB and difference of right and left MD <= 6 dB. 3)Not applicable to contraindication or careful administration of these drugs. 4)Corrected visual acuity >= 0.8 5)Spherical refraction is within –9D to +9D. 6)Difference of right and left Spherical refraction <=3D 7)No any intraocular eye disease 8)No history of intraocular surgery or laser treatment. 9)Subjects who agree to the participation in this study. |
|||
| Key exclusion criteria | Patients not satisfying the above conditions | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhisa Sugiyama |
| Organization | Kanazawa University |
| Division name | Department of Ophthalmology |
| Address | 13-1 Takara-machi, Kanazawa, Ishikawa |
| TEL | |
| Public contact | |
| Name of contact person | Kazuhisa Sugiyama |
| Organization | Kanazawa University |
| Division name | Department of Ophthalmology |
| Address | 13-1 Takara-machi, Kanazawa, Ishikawa |
| TEL | |
| Homepage URL | |
| Sponsor | |
| Institute | Department of Ophthalmology, Kanazawa University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Pfizer Inc |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Fukui Saiseikai Hospital / Ophthalmology |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 金沢大学附属病院(石川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013205 |